EcoDrugPlus

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSAMXG00000009702
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P2y Purinoceptor 12

Ensembl ID : ENSAMXG00000025976
Gene Symbol: LOC103047191
3 Cross references
182 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSAMXG00000019372
Gene Symbol: PTK6B
1 Cross references
160 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSAMXG00000037040
Gene Symbol: PIM3
4 Cross references
164 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSAMXG00000003004
Gene Symbol: LOC103024575
3 Cross references
203 Possible Orthologues:

Raf Proto-Oncogene Serine/threonine-Protein Kinase

Ensembl ID : ENSAMXG00000005440
Gene Symbol: LOC103027930
3 Cross references
156 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSAMXG00000001055
Gene Symbol: RAF1A
1 Cross references
207 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSAMXG00000014672
Gene Symbol: ROCK1
1 Cross references
211 Possible Orthologues:

Sem1 26s Proteasome Complex Subunit

Ensembl ID : ENSAMXG00000032383
Gene Symbol: SEM1
3 Cross references
156 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSAMXG00000039996
Gene Symbol: SRC
1 Cross references
189 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSAMXG00000014517
Gene Symbol: SRC
4 Cross references
189 Possible Orthologues:

Tgf-Beta Receptor Type-1

Ensembl ID : ENSAMXG00000000806
Gene Symbol: LOC103034175
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).